Source:http://linkedlifedata.com/resource/pubmed/id/13059628
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1953-12-1
|
pubmed:abstractText |
Otrivin,(R) a compound of the hydrochloride salt of phenyl-aminomethylimidazoline, was administered to 74 patients for varying periods as a nasal vasoconstrictor. Seventy-three had relief of nasal congestion for from five to six hours-longer periods than had been obtained with other vasoconstrictors they had used. No pressor effect was noted.
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-1264
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
507
|
pubmed:dateRevised |
2008-11-20
|
pubmed:meshHeading | |
pubmed:year |
1953
|
pubmed:articleTitle |
A new vasoconstrictor, a preliminary report.
|
pubmed:publicationType |
Journal Article
|